Three patients with spinal muscular atrophy had improved muscle strength and could walk farther after a month of daily spinal stimulation.
More research is needed to confirm gray matter, the darker tissue found in the brain and spinal cord, “as a potential disease ...
An experimental treatment that stimulates the spinal cord may help people with a paralyzing genetic disorder called spinal muscular atrophy.
Three people with a muscle-destroying disease destined to worsen got a little stronger when an implanted device zapped their ...
WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- A new spinal cord implant may help people with spinal muscular atrophy (SMA) ...
A Boston-area biopharmaceutical firm has submitted a biologics license application to the FDA for its investigational, fully ...
From February 12, all newborn babies will be offered screening for spinal muscular atrophy (SMA), a rare progressive neuromuscular disease. SMA will be one of more than 20 other rare disorders ...
An investigational higher dose of spinal muscular atrophy drug nusinersen gains attention as the FDA and European Medicines ...
From February 12, all newborn babies will be offered screening for spinal muscular atrophy (SMA), a rare progressive neuromuscular disease. SMA will be one of more than 20 other rare disorders ...
In a small human trial in SMA patients neurostimulation sessions improved motoneuron function, reduced fatigue, and improved leg muscle strength and walking.
Study using a new, child-friendly scale found patients up to age 2 had smaller mouth openings than healthy peers, risking ...
12d
Health activists demand government action to reduce the cost of SMA medicines, citing constitutional obligations and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback